Found: 11
Select item for more details and to access through your institution.
Indirect Calorimetry to Measure Metabolic Rate and Energy Expenditure in Psychiatric Populations: A Systematic Review.
- Published in:
- Nutrients, 2023, v. 15, n. 7, p. 1686, doi. 10.3390/nu15071686
- By:
- Publication type:
- Article
Impacts of metabolic disruption, body mass index and inflammation on cognitive function in post-COVID-19 condition: a randomized controlled trial on vortioxetine.
- Published in:
- Annals of General Psychiatry, 2024, v. 23, n. 1, p. 1, doi. 10.1186/s12991-024-00494-1
- By:
- Publication type:
- Article
Association Between Mood Disorders and Risk of COVID-19 Infection, Hospitalization, and Death: A Systematic Review and Meta-analysis.
- Published in:
- 2021
- By:
- Publication type:
- journal article
Vortioxetine for the treatment of post-COVID-19 condition: a randomized controlled trial.
- Published in:
- Brain: A Journal of Neurology, 2024, v. 147, n. 3, p. 849, doi. 10.1093/brain/awad377
- By:
- Publication type:
- Article
Assessing the Effects of Metabolic Disruption, Body Mass Index and Inflammation on Depressive Symptoms in Post-COVID-19 Condition: A Randomized Controlled Trial on Vortioxetine.
- Published in:
- Advances in Therapy, 2024, v. 41, n. 5, p. 1983, doi. 10.1007/s12325-024-02826-9
- By:
- Publication type:
- Article
Lumateperone for the Treatment of Adults With Schizophrenia: a Systematic Review.
- Published in:
- Current Psychiatry Reports, 2022, v. 24, n. 8, p. 359, doi. 10.1007/s11920-022-01344-1
- By:
- Publication type:
- Article
Dextromethorphan-Bupropion for the Treatment of Depression: A Systematic Review of Efficacy and Safety in Clinical Trials.
- Published in:
- CNS Drugs, 2023, v. 37, n. 10, p. 867, doi. 10.1007/s40263-023-01032-5
- By:
- Publication type:
- Article
Molecular Mechanisms of Psilocybin and Implications for the Treatment of Depression.
- Published in:
- CNS Drugs, 2022, v. 36, n. 1, p. 17, doi. 10.1007/s40263-021-00877-y
- By:
- Publication type:
- Article
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
- Published in:
- CNS Drugs, 2021, v. 35, n. 9, p. 925, doi. 10.1007/s40263-021-00846-5
- By:
- Publication type:
- Article
The effect of ketamine on anhedonia: improvements in dimensions of anticipatory, consummatory, and motivation-related reward deficits.
- Published in:
- Psychopharmacology, 2022, v. 239, n. 7, p. 2011, doi. 10.1007/s00213-022-06105-9
- By:
- Publication type:
- Article
Deficits of social cognition in bipolar disorder: Systematic review and meta‐analysis.
- Published in:
- Bipolar Disorders, 2022, v. 24, n. 2, p. 137, doi. 10.1111/bdi.13163
- By:
- Publication type:
- Article